- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/55 - Hydrolases (3)
Patent holdings for IPC class C12N 15/55
Total number of patents in this class: 1277
10-year publication summary
61
|
68
|
65
|
59
|
82
|
109
|
86
|
96
|
97
|
28
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novozymes A/S | 3314 |
44 |
DSM IP Assets B.V. | 5856 |
19 |
Genomatica, Inc. | 514 |
19 |
The Regents of the University of California | 18943 |
17 |
Cellectis | 397 |
17 |
Jiangnan University | 1410 |
16 |
University Health Network | 979 |
15 |
Amano Enzyme Inc. | 324 |
14 |
Codexis, Inc. | 776 |
14 |
President and Fellows of Harvard College | 5792 |
13 |
Pioneer Hi-Bred International, Inc. | 6264 |
10 |
Sangamo Therapeutics, Inc. | 437 |
10 |
Concordia University | 95 |
9 |
The University of Tokyo | 3903 |
9 |
Qingdao Vland Biotech Group Co., Ltd. | 37 |
9 |
Beam Therapeutics Inc. | 176 |
9 |
Universite Laval | 703 |
8 |
BASF SE | 19740 |
7 |
Board of Regents, The University of Texas System | 5370 |
7 |
Precision Biosciences, Inc. | 167 |
7 |
Other owners | 1004 |